Anticancer Medicines

Product Details:

LETFEM 2.5 MG is a medication in tablet form containing 2.5 milligrams (mg) of letrozole. Letrozole is an aromatase inhibitor, a type of medication used primarily in the treatment of hormone receptor-positive breast cancer. In breast cancer, some tumors grow in response to the presence of estrogen, a hormone. Aromatase inhibitors like letrozole work by blocking the enzyme aromatase, which is responsible for the conversion of androgens (male hormones) into estrogen in postmenopausal women. By reducing estrogen levels in the body, letrozole helps to slow down or stop the growth of estrogen-dependent breast cancer cells. LETFEM 2.5 MG (Letrozole 2.5 mg) is commonly prescribed for the following indications: 1. **Early Breast Cancer:** Letrozole may be used as adjuvant therapy (additional treatment after primary therapy such as surgery) in postmenopausal women with hormone receptor-positive early breast cancer to reduce the risk of cancer recurrence. 2. **Metastatic Breast Cancer:** Letrozole may also be used as first-line or subsequent therapy for the treatment of metastatic (advanced) breast cancer in postmenopausal women. It's important to use LETFEM 2.5 MG (Letrozole 2.5 mg) only under the supervision of a healthcare professional and for the specific purpose for which it has been prescribed. Letrozole may cause side effects such as hot flashes, joint pain, fatigue, and osteoporosis, so it's essential to discuss any concerns or potential interactions with other medications with your healthcare provider.

Additional Information:

• Production Capacity: 25000 Strips per month
• Delivery Time: 2-5 Days
• Packaging Details: ALL MEDICINES ARE WELL PACKED IN BROWN CARD BOX WITH THARMACOLE AND PLASTIC TO MAKE DECENT PACKING AND PREVENT FROM ANY TYPE OF PRODUCT DAMAGE .

Product Details:

Letrozole 2.5 mg tablet is a prescription oral medication classified as a non-steroidal aromatase inhibitor. It is primarily used in women with hormone-sensitive breast cancer and off-label in fertility treatments and bodybuilding for estrogen control.

• Letrozole blocks the aromatase enzyme, which converts androgens (testosterone) into estrogens in fat and other tissues.

• By inhibiting estrogen synthesis, it helps slow or prevent the growth of estrogen receptor–positive (ER+) tumors.

💊 Strength & Dosage Form

• Each tablet contains 2.5 mg of letrozole.

• Usually comes in strip packs of 5 or 10 tablets.

• Common Indian brands: Femara, Letoval, Letroz, Letronat, Letz.

✅ Approved Medical Uses 🧬 Off-Label Uses ⚙️ How Letrozole Works

• Inhibits aromatase → ↓ estrogen synthesis

• In women, less estrogen slows growth of ER+ breast cancer

• In men, lower estrogen → increased LH/FSH → ↑ testosterone

• In fertility, reduced estrogen feedback → pituitary releases more FSH → stimulates ovulation

🕒 Dosage & Schedule 🔹 Breast Cancer (standard use)

• 2.5 mg once daily (long-term therapy, often 5 years)

🔹 Fertility (PCOS / anovulation)

• 2.5 to 7.5 mg/day from day 3 to 7 of the menstrual cycle

• Sometimes higher doses (up to 12.5 mg) under specialist supervision

🔹 Bodybuilding / PCT (off-label)

• 0.25 to 2.5 mg, 2–3 times/week

• Dose depends on steroid cycle strength and estrogen conversion potential

• Used with testosterone-based steroid cycles to prevent:

  • Gynecomastia

  • Bloating / water retention

  • Mood swings / estrogen rebound

🔄 Comparison: Letrozole vs Anastrozole vs Exemestane ⚠️ Side Effects In Women:

• Hot flashes

• Vaginal dryness

• Bone thinning (osteoporosis)

• Fatigue

• Joint pain

• Mood swings

Additional Information:

• Production Capacity: 25000 Strips per month
• Delivery Time: 2-5 Days
• Packaging Details: ALL MEDICINES ARE WELL PACKED IN BROWN CARD BOX WITH THARMACOLE AND PLASTIC TO MAKE DECENT PACKING AND PREVENT FROM ANY TYPE OF PRODUCT DAMAGE .

Product Details:

 

Sirolimus Tablets (Rapamycin)

Sirolimus is an immunosuppressant drug, mainly used to prevent organ transplant rejection and sometimes in certain rare diseases or cancers.

🔹 Composition

• Active ingredient: Sirolimus (various strengths, usually 1 mg, 2 mg, or higher depending on brand).

• Dosage form: Oral tablets.

🔹 Mechanism of Action

• Sirolimus is an mTOR (mammalian target of rapamycin) inhibitor.

• It works by blocking T-cell and B-cell activation and proliferation (immune cells responsible for attacking transplanted organs).

• Unlike calcineurin inhibitors (like Tacrolimus or Cyclosporine), it does not cause nephrotoxicity directly but can affect kidney function indirectly.

🔹 Indications

1. Primary use:

   • Prevention of kidney transplant rejection (often used with corticosteroids and cyclosporine initially, then sometimes as maintenance therapy).

2. Other uses (off-label/rare):

   • Certain rare cancers and tumors (e.g., renal cell carcinoma, Kaposi’s sarcoma).

   • Lymphangioleiomyomatosis (LAM): a rare lung disease, especially in women.

   • Research use in anti-aging/longevity medicine (not officially approved).

🔹 Dosage (General Guidelines)

• Kidney transplant:

  • Loading dose: ~6 mg orally, followed by maintenance dose of 2 mg daily.

  • Adjusted according to blood trough levels (therapeutic drug monitoring is essential).

• Dose always individualized by the transplant physician.

• Taken consistently with or without food (but always the same way each time for steady absorption).

🔹 Side Effects

Common:

• Mouth ulcers / sores.

• High cholesterol and triglycerides.

• Anemia, low platelet counts.

• Delayed wound healing.

• Swelling in legs (peripheral edema).

• Diarrhea, abdominal pain.

Serious (require monitoring):

• Infections (due to suppressed immunity).

• Interstitial lung disease (rare but serious).

• Kidney function impairment (especially if combined with cyclosporine).

• Hepatic artery thrombosis (in liver transplant – contraindicated).

• Increased risk of certain cancers (lymphoma, skin cancer).

🔹 Monitoring

• Sirolimus blood levels (trough concentration monitoring).

• Kidney function tests (serum creatinine).

• Liver function tests.

• Lipid profile (cholesterol, triglycerides).

• Blood counts.

🔹 Contraindications

• Hypersensitivity to sirolimus.

• Use in liver and lung transplants (associated with higher complication risk).

• Pregnancy and breastfeeding (safety not established).

🔹 Drug Interactions

• Metabolized by CYP3A4 enzyme and P-glycoprotein.

• Many drug interactions (e.g., ketoconazole, clarithromycin, rifampicin, anticonvulsants, grapefruit juice) → can greatly change sirolimus blood levels.

🔹 Important Precautions

• Avoid live vaccines during therapy.

• Protect from sun (higher skin cancer risk).

• Regular monitoring is mandatory.

 

Additional Information:

• Production Capacity: 25000 Strips per month
• Delivery Time: 2-5 Days
• Packaging Details: ALL MEDICINES ARE WELL PACKED IN BROWN CARD BOX WITH THARMACOLE AND PLASTIC TO MAKE DECENT PACKING AND PREVENT FROM ANY TYPE OF PRODUCT DAMAGE .